Sichuan Zhishan Weixin Biotechnology
Latest round
- Series B
Last raised
- Dec 2025
Total raised
- Undisclosed
Investors
- 14
About Sichuan Zhishan Weixin Biotechnology
, trading as Sichuan Zhishan Weixin Biotechnology, is a company developing original new drugs for gene therapy, focusing on the development of original new drugs for rAAV gene therapy. The company has several patents and technologies in gene expression cassette design and vector production optimization, while the founder, Prof. Biao Dong, has been engaged in rAAV research for years. The company's core staff has rich experience in gene therapy drug design, preclinical research, and CMC development. The company is mainly developing original new drugs for rAAV gene therapy, with a pipeline in development covering multiple clinical indications such as hematology, central nervous system, and metabolic system. The company's first self-developed product is ZS801, an gene therapy product for hemophilia B, which has received clinical approval in August 2022. The company also has a novel pox-adenovirus rAAV production system. The company generates revenue from providing original new drugs for gene therapy.
Who invested in Sichuan Zhishan Weixin Biotechnology
14 investors across 5 rounds
See all investors in Sichuan Zhishan Weixin Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sichuan Zhishan Weixin Biotechnology
Who invested in Sichuan Zhishan Weixin Biotechnology?
Sichuan Zhishan Weixin Biotechnology has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sichuan Zhishan Weixin Biotechnology raised?
Sichuan Zhishan Weixin Biotechnology has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Sichuan Zhishan Weixin Biotechnology last raise money?
Sichuan Zhishan Weixin Biotechnology's most recent round on record is a Series B, in Dec 2025.
What does Sichuan Zhishan Weixin Biotechnology do?
, trading as Sichuan Zhishan Weixin Biotechnology, is a company developing original new drugs for gene therapy, focusing on the development of original new drugs for rAAV gene therapy.
Where is Sichuan Zhishan Weixin Biotechnology headquartered?
Sichuan Zhishan Weixin Biotechnology is headquartered in Chengdu, China.
Which VCs invest in companies like Sichuan Zhishan Weixin Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Sichuan Zhishan Weixin Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sichuan Zhishan Weixin Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.